Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
05/2005
05/12/2005WO2005041962A1 Solid preparation comprising an insulin sensitizer, an insulin secretagogue and a polyoxyethylene sorbitan fatty acid ester
05/12/2005WO2005041958A1 Novel compositions
05/12/2005WO2005041945A1 Composition containing reduced coenzyme q
05/12/2005WO2005041943A1 Transdermal pharmaceutical spray formulations comprising a vp/va copolymer and a non-aqueous vehicle
05/12/2005WO2005041942A2 Three-dimensional mammalian ovarian follicular cell and ovarian follicle culture systems in a biocompatible matrix
05/12/2005WO2005041941A2 Valsartan containing formulation
05/12/2005WO2005041940A1 Stable formulations of ace inhibitors and methods for preparation thereof
05/12/2005WO2005041939A1 Pharmaceutical formulations for carrier-mediated transport statins and uses thereof
05/12/2005WO2005041938A1 Non-effervescent form of sodium naproxen comprising i.a. sodium hydrogen carbonate
05/12/2005WO2005041937A2 Controlled release sterile injectable aripiprazole formulation and method
05/12/2005WO2005041936A2 Methods of treatment of cancer using a composition comprising a cytotoxic drug and a porous carrier material
05/12/2005WO2005041935A1 Pharmaceutical formulations containing quetiapine
05/12/2005WO2005041934A2 Pharmaceutical agent-containing formulation comprising a coating
05/12/2005WO2005041933A1 Nanoparticles for drug delivery
05/12/2005WO2005041932A2 Method for selecting cationic or anionic liposomes for treatment of a mucosa membrane, and kit comprising the same
05/12/2005WO2005041931A2 Pharmaceutical aerosol compositions
05/12/2005WO2005041930A1 Monodispersed solid lipid particle compositions
05/12/2005WO2005041929A1 Pharmaceutical compositions with synchronized solubilizer release
05/12/2005WO2005041928A1 Compositions and dosage forms for ehnanced absorption of iron
05/12/2005WO2005041927A1 Compositions and dosage forms for enhanced absorption of gabapentin and pregabalin
05/12/2005WO2005041926A1 Compositions and dosage forms for enhanced absorption of 3-amino-n-butyl-phosphinic acid
05/12/2005WO2005041925A2 Compositions and dosage forms for enhanced absorption
05/12/2005WO2005041924A2 Administration of levodopa and carbidopa
05/12/2005WO2005041923A1 Compositions and dosage forms for enhanced absorption of metformin
05/12/2005WO2005041922A2 Composition
05/12/2005WO2005041921A2 Dry powder compositions for inhalation therapy comprising calcium stearate, medical devices therefor
05/12/2005WO2005041920A2 Pharmaceutical licofelone formulation
05/12/2005WO2005041919A2 Medicamentously targeted local lipolysis
05/12/2005WO2005041907A1 Antimicrobial shampoo compositions
05/12/2005WO2005041889A2 Personal care composition containing a detersive surfactant, an antidandruff component, and ketoamide surfactants
05/12/2005WO2005041883A2 Reduction of unintended use of transdermal devices
05/12/2005WO2005041878A2 Compositions and methods for increasing hdl and hdl-2b levels
05/12/2005WO2005041876A2 Spill resistant formulations containing clays
05/12/2005WO2005041871A2 Apparatus and method for enhancing transdermal drug delivery
05/12/2005WO2005041869A2 Process for co-spray drying agents with dry silicified mcc
05/12/2005WO2005041866A2 Pharmaceutical formulations, methods and dosing regimens for the treatment and prevention of acute coronary syndromes
05/12/2005WO2005041855A2 Pharmaceutical formulation containing an ltb4 antagonist, method for the production thereof, and use thereof
05/12/2005WO2005041684A2 Novel flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof
05/12/2005WO2005041660A1 Antimicrobial composites, films, labelstocks and labels
05/12/2005WO2005032555A3 Pharmaceutical combinations of hydrocodone and naltrexone
05/12/2005WO2005027859A3 Patch
05/12/2005WO2005026083A3 Improved delivery by labile hydrophobic modification of drugs
05/12/2005WO2005025545A3 Pharmaceutical formulation for controlled release of selodenoson
05/12/2005WO2005025541A3 Dry powder composition comprising a benzodiazepine for pulmonary inhalation
05/12/2005WO2005025536A3 Dry powder composition comprising co-jet milled particles for pulmonary inhalation
05/12/2005WO2005025488A3 Methods for the controlled delivery of pharmacologically active compounds
05/12/2005WO2005021042A8 Active energy radiation hardenable skin plaster composition and skin plaster
05/12/2005WO2005018600A3 Method of treating a patient suffering from a solid tumour
05/12/2005WO2005007185A3 Formulation for a protein pharmaceutical without added human serum albumin (hsa)
05/12/2005WO2005007139A3 Multiparticle pharmaceutical dosage form containing a mucoadhesively formulated peptide or protein active substances method for producing said pharmaceutical dosage form
05/12/2005WO2005004916A3 Modified calcium phosphate excipient
05/12/2005WO2005004836A3 Saquinavir mesylate oral dosage form
05/12/2005WO2005004804A3 Compositions and methods for selective dissolution of nascent intravascular blood clots
05/12/2005WO2005000270A3 Inhalable formulations for treating pulmonary hypertension and methods of using same
05/12/2005WO2005000265A3 Gel-stabilized nanoparticulate active agent compositions
05/12/2005WO2004103311A3 Antibiotic composition
05/12/2005WO2004096127A3 Formation of strong superporous hydrogels
05/12/2005WO2004091572A3 Cochleate compositions directed against expression of proteins
05/12/2005WO2004084703A3 Temporary embolization using inverse thermosensitive polymers
05/12/2005WO2004082666A3 Mssn dispersion and method for producing the same
05/12/2005WO2004066903A3 Active drug delivery in the gastrointestinal tract
05/12/2005WO2004064752A3 Method of preparing sustained release microparticles
05/12/2005WO2004039358A8 Adhesive composition for dermal patch and production process thereof
05/12/2005WO2004017918A8 Method of preparing dry powder inhalation compositions
05/12/2005WO2003087159A8 Modulators of the notch signalling pathway and uses thereof in medical treatment
05/12/2005WO2001079525A3 Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same
05/12/2005US20050101943 Modular imbibition rate reducer for use with implantable osmotic pump
05/12/2005US20050101942 Device and method for accurate delivery of an active agent
05/12/2005US20050101936 Multi-site drug delivery platform
05/12/2005US20050101762 Cyclic peptide for use as tool in transmembrane transport; drug delivery
05/12/2005US20050101671 Compounds and compositions for delivering active agents
05/12/2005US20050101635 Delivering to an external portion of the body passageway of a patient in need of a therapeutically effective amount of an antihistamine or decongestant to treat inflammatory diseases
05/12/2005US20050101625 Aerosol formulation for inhalation comprising an anticholinergic
05/12/2005US20050101611 Oral formulation comprising an inhibitor compound of the ileal bile transport and an hmg co-a reductase inhibitor
05/12/2005US20050101606 Sustained-release preparation containing 5-acetyl-4,6-dimethyl-2[2-[4-(2-methoxyphenyl) piperazinyl]ethylamino]pyrimidine trihydrochloride as active ingredient
05/12/2005US20050101582 Compositions and methods for treating a posterior segment of an eye
05/12/2005US20050101580 Cream base emulsion containing tretinoin, hydroquinone, and fluocinolone acetonide for treatment of hyperpigmented skin conditions such as melasma
05/12/2005US20050101562 Lipase inhibiting composition
05/12/2005US20050101557 Immunostimulatory nucleic acid molecules
05/12/2005US20050101554 Methods for treating and preventing infectious disease
05/12/2005US20050101546 Increased solubility flavanolignan preparations
05/12/2005US20050101544 Such as montelukast, zafirlukast or pranlukast; low amounts of active agents, less prone to detrimental side effects
05/12/2005US20050101533 Dried blood factor composition comprising trehalose
05/12/2005US20050101525 Method of complexing a nucleic acid with a lipid-conjugated polyamide
05/12/2005US20050101524 Using arsenic oxide, or complex thereof; angiogenesis inhibitors; anticarcinogenic agents; neurodegenerative agents; antiischemic agents
05/12/2005US20050101522 Antihyperplastic agents; antitumor agents; side effect reduction
05/12/2005US20050101517 An oily solution of testosterone decanoate suitable for injections; male contracepti ves
05/12/2005US20050101020 Methods and products for delivering biological molecules to cells using multicomponent nanostructures
05/12/2005US20050100918 Mammalian receptor proteins; related reagents and methods
05/12/2005US20050100917 Mammalian receptor proteins; related reagents and methods
05/12/2005US20050100907 Method and medicament for inhibiting the expression of a given gene
05/12/2005US20050100651 Method for a enhancing the desirability of a breakfast cereal
05/12/2005US20050100648 Method for a consumer to flavor a food or beverage using three or more balanced flavoring agents
05/12/2005US20050100647 Method for creating an intense flavor sensation by use of tongue dropsicles
05/12/2005US20050100639 Method for a consumer to create his own tasty beverage
05/12/2005US20050100621 comprising urea as an active ingredient, a vegetable oil or vegetable oil derivative, water, and conventional excipients
05/12/2005US20050100618 Manual clitoral sensitizing mixture having a cooling agent chosen from oils of peppermint, cornmint, eucalyptus, camphor, citronella and cinnamon
05/12/2005US20050100615 controling metabolic acidosis due to burn injury, hemorrhagic shock, multiple organ failure, systemic inflammatory response syndrome (SIRS); administering sodium bicarbonate
05/12/2005US20050100612 Virucidal activities of cetylpyridinium chloride
05/12/2005US20050100611 Administering a therapeutically effective amount of arsenic compounds, optionally along with other non-arsenic therapeutic agents, to a mammal for treating solid tumors
1 ... 1820 1821 1822 1823 1824 1825 1826 1827 1828 1829 1830 1831 1832 1833 1834 1835 1836 1837 1838 1839 1840 ... 2991